20 ML mirvetuximab soravtansine-gynx 5 MG/ML Injection
RxNorm concept 2621553, clinical drug (scd). Prescribable name: mirvetuximab soravtansine-gynx 100 MG in 20 ML Injection.
- RxCUI
- 2621553
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2621553 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
mirvetuximab soravtansine-gynx 100 MG per 20 ML Injection; mirvetuximab soravtansine-gynx 5 MG/ML per 20 ML Injection
Related concepts
- mirvetuximab soravtansine-gynx 5 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 20 ML mirvetuximab soravtansine-gynx 5 MG/ML Injection [Elahere] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2621553 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2621553 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2621553. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.